Joslin Diabetes Center Executive and Leadership Team

Roberta Herman, the President & Chief Executive Officer at Joslin Diabetes Center, directs the overarching strategic vision for clinical research initiatives. Herman architects long-term growth plans while overseeing the integration of advanced medical protocols across the organization. By aligning research objectives with patient care standards, the President & Chief Executive Officer ensures the center maintains a premier position in the global diabetes community. Roberta Herman manages high-level partnerships with academic institutions to accelerate the translation of laboratory discoveries into practical clinical applications. This leadership role involves constant evaluation of medical outcomes to drive excellence in treatment delivery. Through rigorous oversight of clinical programs, the President & Chief Executive Officer fosters an environment of innovation. Herman secures the necessary resources to support complex research projects, ultimately enhancing the quality of life for patients worldwide. The President & Chief Executive Officer remains focused on expanding the reach of specialized diabetes care through strategic collaborations.

Peter Amenta, the President & Chief Executive Officer at Joslin Diabetes Center, governs the administrative framework and institutional governance of the organization. Amenta drives the development of educational programs designed to train the next generation of diabetes specialists. By focusing on the academic mission, the President & Chief Executive Officer ensures the center remains a hub for medical knowledge and professional development. Peter Amenta coordinates with the Board to maintain fiscal health and operational integrity across all departments. This leadership role requires balancing complex regulatory requirements with the pursuit of scientific breakthroughs. Amenta oversees the implementation of internal policies that support staff productivity and research efficiency. The President & Chief Executive Officer champions initiatives that broaden the impact of diabetes education on a national scale. Through consistent engagement with medical stakeholders, Amenta strengthens the reputation of the center as a leader in diabetes management and specialized patient care.

Kristil Smith, the Chief Financial Officer at Joslin Diabetes Center, manages the fiscal health and long-term economic sustainability of the organization. Smith architects robust financial models to support ongoing research projects and clinical operations. By overseeing capital allocation, the Chief Financial Officer ensures that resources flow efficiently toward high-impact medical initiatives. Kristil Smith directs the budgeting process and monitors financial performance against strategic goals. This leadership role involves managing complex funding streams from grants, clinical revenue, and philanthropic contributions. Smith provides critical financial insights to the executive team to guide decision-making regarding facility expansion and technology investments. The Chief Financial Officer maintains strict compliance with financial regulations while optimizing cost structures to maximize the reach of patient services. Through diligent fiscal oversight, Smith secures the financial foundation necessary for the center to continue its mission of providing world-class diabetes care and research.

Susan Lit, the Interim President & Chief Operating Officer at Joslin Diabetes Center, executes the daily operational strategies that sustain clinical excellence. Lit oversees the seamless integration of patient care services and administrative workflows. By optimizing internal processes, the Interim President & Chief Operating Officer ensures that clinical teams operate with maximum efficiency. Susan Lit manages the infrastructure requirements for the center, including the maintenance of specialized medical facilities. This leadership role involves coordinating cross-functional teams to improve patient throughput and service quality. Lit monitors operational metrics to identify areas for improvement and implements solutions that enhance the overall patient experience. The Interim President & Chief Operating Officer drives initiatives that streamline communication between research departments and clinical staff. Through proactive management of daily operations, Lit supports the organizational mission of delivering superior diabetes care while maintaining high standards of safety and operational performance.